Translating genotype data of 44,000 biobank participants into clinical pharmacogenetic recommendations: challenges and solutions

Abstract

We find that microarrays are a cost-effective solution for creating preemptive pharmacogenetic reports, and with slight modifications, existing databases can be applied for automated pharmacogenetic decision support for clinicians.